Larvol Delta - CERo-Therapeutics-Inc-Announces-Publication-of-Preclinical-Research-Supporting-the-Use-of-Its-Clinical-Candidate-CER1236-to-Treat-AML-Patients

CER-1236 - CERo Therap

https://www.businesswire.com/news/home/20240307755964/en/CERo-Therapeutics-Inc.-Announces-Publication-of-Preclinical-Research-Supporting-the-Use-of-Its-Clinical-Candidate-CER-1236-to-Treat-AML-Patients

Mar 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next